Primo Brands' Premium Portfolio Growth: A Modest Positive but Not a Thesis Changer

What happened

On September 24, 2026, Zacks Investment Research highlighted a 30.5% increase in Primo Brands' premium portfolio volume, attributing the gains to brand building and expanded distribution for Saratoga and Mountain Valley. This development aligns with management's earlier plans to expand premium capacity, including the Mountain Valley facility slated to be operational by spring 2026, indicating some traction in the premium segment. However, the core concerns from the DeepValue master report remain unaddressed: direct-delivery comparable sales declined 6.5% in Q3 2025, customer credits increased, integration costs were still $44.2 million that quarter, and net leverage stood at 7.3x. The premium segment represents only a portion of the business, and the recurring direct-delivery economics—the primary swing factor for the stock's re-rating—have not shown clear evidence of stabilization in available filings. Consequently, while the premium growth is a modest positive, it does not alter the overall WAIT rating unless accompanied by visible improvements in direct-delivery service, credit trends, and integration cost step-downs.

Implication

Investors should view the 30.5% premium growth as a sign that the company is capturing demand in higher-margin water categories, which could improve mix and profitability if sustained. However, this is a product-line story, not a distribution-network story, and the bear case hinges on service reliability and route economics in direct delivery. Without visible improvement in direct-delivery comparable sales (currently -6.5%) and a decline in customer credits, the premium gains do not mitigate the risk of further service-driven volume losses. Await Q4 2025 and Q1 2026 earnings to see whether premium momentum translates into consolidated margin improvement and whether integration costs step down from the $44.2 million quarterly run-rate. Until then, the stock remains a wait, with attractive entry near $16 and trim above $24; add only if direct-delivery and cost metrics show clear inflection.

Thesis delta

The thesis delta is minimal; the premium portfolio growth does not address the primary drivers of direct-delivery stabilization and integration cost reduction. The WAIT rating and valuation scenarios in the master report remain unchanged, with the stock still exposed to high leverage and refinancing dependency. While premium gains could be a marginal positive for the bull case if confirmed by official filings, they are not sufficient to shift the probability-weighted assessment.